Event Brief
May 31, 2026 at 6:00 PM ET
Ivonescimab extends survival in lung cancer patients
By The BriefBrief
Patients treated with ivonescimab lived about four months longer than those on immunotherapy.
WHO: Patients treated with ivonescimab
WHAT: Ivonescimab treatment resulted in longer survival than immunotherapy in lung cancer patients.
WHEN: May 31, 2026 at 10:06 AM ET
WHERE: Location not specified
WHY: Cause not yet established.
Reporting from 2 identified publishers across this event arc.
View all 2 publishers
Publishers represented across this event arc
These publishers contributed reporting to the broader event history. Not every source addresses the specific development described above.
How this brief is built: The BriefBrief correlates multiple sources into one evolving event brief, updated as new facts emerge.
$60,000 reward offered for suspect in deputy shooting
Us
May 31, 2026 at 6:00 PM ET
Syria’s al-Sharaa holds phone call with Trump
Syria
May 31, 2026 at 5:05 PM ET
Four people trapped in flooded cave in Laos rescued
Laos
May 31, 2026 at 5:05 PM ET
Zelenskyy urges US to send more anti-ballistic missiles
World
May 31, 2026 at 5:05 PM ET
Page 16985 of 21461
Same format. Every time.
Continue reading — sign in or create a free account with
